{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T14:19:36Z","timestamp":1725373176795},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.diagmicrobio.2008.06.007","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T12:51:26Z","timestamp":1219323086000},"page":"210-215","source":"Crossref","is-referenced-by-count":10,"title":["In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain"],"prefix":"10.1016","volume":"62","author":[{"given":"Cristina","family":"Seral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rubio-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"G\u00f3mez-Lus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Gimeno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Coronel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estrella","family":"Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Becerril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Oca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Javier","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0732-8893(91)90068-Q","article-title":"In vitro activity of a new cephalosporin ME-1206 compared with other agents","volume":"14","author":"Chin","year":"1991","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/jac\/dkf076","article-title":"Activity of cefditoren against respiratory pathogens","volume":"50","author":"Clark","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib1","series-title":"Document M7-A7","article-title":"Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: approved standard","author":"Clinical Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib2","series-title":"Document M100-S18","article-title":"Performance standards for antimicrobial susceptibility testing: 18th informational supplement","author":"Clinical Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib5","first-page":"127","article-title":"An in vitro characterization of cefditoren, a new oral cephalosporin","volume":"20","author":"Felmingham","year":"1994","journal-title":"Drugs Exp. Clin. Res."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib6","first-page":"39","article-title":"Activity of cefpodoxime and other oral \u03b2-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin","volume":"19","author":"Fenoll","year":"2006","journal-title":"Rev. Esp. Quimioter."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/dkm209","article-title":"Influence of the \u03b2-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media","volume":"60","author":"Fenoll","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2006.08.046","article-title":"Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones","volume":"29","author":"Fenoll","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jac\/37.5.1038","article-title":"In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis","volume":"37","author":"Fernandez-Roblas","year":"1996","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0732-8893(00)00160-7","article-title":"Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria","volume":"37","author":"Fuchs","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib11","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1128\/AAC.00354-07","article-title":"Ampicillin-resistant non-\u03b2-lactamase\u2013producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime","volume":"51","author":"Garcia-Cobos","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl S2","key":"10.1016\/j.diagmicrobio.2008.06.007_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/dkf503","article-title":"Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project","volume":"50","author":"Garcia-de-Lomas","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0732-8893(00)00136-X","article-title":"Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species","volume":"37","author":"Johnson","year":"2000","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0732-8893(98)00044-3","article-title":"In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae","volume":"31","author":"Jones","year":"1998","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0732-8893(01)00274-7","article-title":"Cefditoren in vitro activity and spectrum: a review of international studies using reference methods","volume":"41","author":"Jones","year":"2001","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib16","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1128\/AAC.48.5.1630-1639.2004","article-title":"Genetic and molecular characterization of \u03b2-lactamase\u2013negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin","volume":"48","author":"Kaczmarek","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0732-8893(01)00304-2","article-title":"In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren","volume":"42","author":"Karlowsky","year":"2002","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib18","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1128\/JCM.37.10.3296-3299.1999","article-title":"Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae","volume":"37","author":"Kelly","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijantimicag.2006.02.014","article-title":"In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries","volume":"28","author":"Lee","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.46.5.1273-1280.2002","volume":"46","author":"Nagai","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib21","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.49.5.1965-1972.2005","article-title":"Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain","volume":"49","author":"Perez-Trallero","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/jac\/48.2.279","article-title":"In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992\u20131998","volume":"48","author":"Reinert","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1179\/joc.1999.11.3.191","article-title":"Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents","volume":"11","author":"Rubio","year":"1999","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib24","first-page":"506","article-title":"Presence of conjugative transposon Tn1545 in strains of Streptococcus pneumoniae with mef(A), erm(B), tet(M), catpc194 and aph(3\u2032)-III genes","volume":"18","author":"Seral","year":"2000","journal-title":"Enferm. Infecc. Microbiol. Clin."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/47.6.863","article-title":"Distribution of resistance genes tet(M), aph(3\u2032)-III, catpc194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain","volume":"47","author":"Seral","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1179\/joc.2003.15.2.107","article-title":"Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae isolated in four southern European countries (ARISE project) from adult patients: results from the cefditoren surveillance program","volume":"15","author":"Soriano","year":"2003","journal-title":"J. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib27","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijantimicag.2003.07.018","article-title":"Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project","volume":"23","author":"Soriano","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/jac\/39.2.141","article-title":"Time\u2013kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other \u03b2-lactams","volume":"39","author":"Spangler","year":"1997","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib29","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1128\/AAC.32.9.1421","article-title":"In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin","volume":"32","author":"Tamura","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib30","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/AAC.00743-07","article-title":"Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2x: structural basis for its high antimicrobial activity","volume":"51","author":"Yamada","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.06.007_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1128\/AAC.42.3.555","article-title":"In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem","volume":"42","author":"Yamaguchi","year":"1998","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308002952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308002952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T21:19:32Z","timestamp":1588886372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308002952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0732889308002952"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.06.007","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}